Device Trial Radar · NCT05610111
Adaptive Biobehavioral Control (ABC) in a Closed-Loop System
Last checked: Nov 20, 2026Latest source record: Jul 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
73
Actual
Start
Jan 18, 2023
Primary completion
Sep 26, 2024
Study completion Sep 28, 2024
Sponsor
- Lead sponsor
- Sue BrownAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Tandem Diabetes Care, Inc.
- First posted
- Nov 9, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is intended to test a Web-based Information Tool (WIT) software providing additional information regarding time in range, GMI, hypo- and hyperglycemia risks, variability tracker, daily glycemic profiles, and potential changes of insulin pump parameters, to users of a commercially available Closed-Loop Control (CLC) System (Control-IQ Technology).
Conditions
- Type 1 Diabetes
Interventions
CLC + BAMDevice
Closed Loop Control with the Behavioral Adaption Module for 4 weeks
CLC + ABCDevice
Closed Loop Control with Adaptive Biobehavioral Control for 16 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- CGM-measured Percent Time in Range 70-180 mg/dLTime frame: 2 weeks of CLC, 4 weeks of CLC+BAM, last 4 weeks of CLC+ABC
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Virginia Center for Diabetes Technology
Charlottesville, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.